)
)
Sage Therapeutics Investor Relations Material
Latest events
Q4 2024
Sage Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Sage Therapeutics Inc
Access all reports
Sage Therapeutics, Inc., operates as a biopharmaceutical company, which focuses on the development and commercialization of medicines to treat central nervous system disorders. Its products include, for example, SAGE-547 and SAGE-217.
Key slides for Sage Therapeutics Inc
Q2 2024
Sage Therapeutics Inc
Q2 2024
Sage Therapeutics Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
SAGE
Country
🇺🇸 United States